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Aim: To understand how surgeons arrive at a decision in the complex and controversial ﬁeld of radio-
therapy in rectal cancer by identifying which variables are important in this decision and to assess the
inﬂuence of age, training, area of practice and access to radiotherapy on decisions in this ﬁeld.
Methods: A self-administered survey was distributed to 150 members of the CSSANZ. They were asked to
rank the importance of 33 variables considered when making decisions to use radiotherapy in the
treatment of rectal cancer. The responses were assessed for association of surgeon age, area of practise or
access to radiotherapy with decisions in this ﬁeld.
Results: A hierarchy of variables was produced which showed tumour characteristics had the highest
average importance, higher than that attained by patient characteristics and side effects.
There were subtle but statistically signiﬁcant differences in the ranking of importance when surgeons
were grouped by age, site of subspeciality training, site of practise and availability of radiotherapy
service.
Conclusion: This study identiﬁes a hierarchy of variables used in decision making concerning radio-
therapy in rectal cancer treatment, which may be used in heuristic decision making.
Decisions on using radiotherapy are inﬂuenced by age, site of practise, site of training, and the presence
of radiotherapy on site.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Despite multiple randomized controlled trials, the use of
radiotherapy in the treatment of rectal cancer continues to span a
broad spectrum fromno adjuvant radiotherapy at all, to therapeutic
radiotherapy as the deﬁnitive treatment [1,2].
The large volumes of evidence required to be incorporated into a
decision onwhen, if, and how, to use radiotherapy in the treatment
of rectal cancer can cause uncertainty. The study of decisionmaking
under uncertainty dates back to the 18th century [3]. Insight into
uncertainty and the impact of bias has been demonstrated in the
medical literature [4]. A widely accepted decision making model is
the dual system theory [5] which proposes a spectrum between
two methods: intuition (System 1) and reasoning (System 2) [6,7].
Intuitive thinking has been described as heuristic and is charac-
terized as being fast, impulsive, and reﬂexive but error prone [8].l Medical Centre, 100 Carillon
by Elsevier Ltd. All rights reservedThis type of decision making uses cues to minimize mental effort in
uncertain and time-pressured environments. The cues used by the
decision maker are subject to the individual’s preferences. In
contrast, reasoning is slow, explicit, deliberate, and thought to be
more reliable but can be overwhelmed by large amounts of infor-
mation. Either mode can override the other but in situations of time
pressure the intuitive mode is likely to dominate.
In many countries multidisciplinary team (MDT) decisions
determine the patient’s treatment course and have become the
standard of care [9]. Uncertainty or bias in decision making con-
cerning radiotherapy is thought to be abrogated by the MDT. In
team decision making both the leader and the information pre-
sented has a signiﬁcant inﬂuence on the process. The leader in MDT
is often the surgeon and the decision making process employed by
this individual becomes important due to its signiﬁcant inﬂuence
the MDT process. In addition, understanding decision making may
optimize the MDT process [9,10].
In order to understand how surgeons make a decision in a
complex environment, we conducted a survey study aiming to
deﬁne the important variables that are considered by surgeons.
Table 1
Overall ranking of variables as assigned by 105 CSSANZ surgeons.
Variable Min Median Max
Tumour stage 2 10.0 10
Desire to reduce rate of local recurrence 4 10.0 10.0
Desire to downstage tumour to maximise
chance of resection with clear radial margins
8.0 9.0 10.0
Staging with MRI 8.0 9.0 10.0
Tumour at lower third of rectum 8.0 9.0 10.0
Evidence supporting radiotherapy 8.0 9.0 10.0
Nodal status 7.0 8.0 10.0
Distance of tumour from anal verge 7.0 8.0 9.0
Tumour at middle third of rectum 7.0 8.0 9.0
Downstage tumour to allow resection 6.0 8.0 9.0
Consensus of MDT 6.0 8.0 9.0
Desire to maximise overall survival 3.3 7.5 10.0
Tumour position 5.0 7.0 9.0
Your personal experience or observations 5.0 7.0 8.0
Desire to avoid functional bowel problems 5.0 7.0 8.0
Experience, observations and opinions of
colorectal surgical colleagues
4.3 7.0 8.0
Your patient’s ASA 4.0 7.0 8.0
The policy of your colorectal surgery unit toward
radiotherapy
3.0 6.0 8.0
Your patient’s age 4.0 6.0 8.0
Presence of resectable metastatic disease 4.0 5.5 8.0
Desire to minimise chance of long term pelvic pain 3.0 5.0 8.0
Access to radiotherapy service 2.0 5.0 8.0
Desire to downstage tumour in order to preserve anal
sphincter
2.0 5.0 8.0
Desire to avoid urinary problems 3.0 5.0 7.0
Desire to minimise chance of sexual dysfunction 3.0 5.0 7.0
Desire to minimise chance of pelvic sepsis 2.0 4.0 6.0
Desire to minimise chance of wound infection 2.0 3.5 5.8
Staging with transanal ultrasound 0 3.5 8.0
Desire to avoid permanent stoma 2.0 3.0 6.8
Tumour at upper third of rectum 1.0 3.0 6.0
Patient’s gender 0 2.0 5.0
Downstage tumour to allow transanal excision of early
cancer
0 1.0 3.0
To permit a ’wait and see’ approach 0 1.0 2.0
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assess if such decisions are inﬂuenced by age, site of training,
location of practice and availability of radiotherapy.
2. Methods
A self-administered survey was developed which asked sur-
geons to use a Lickert scale to rate the importance of 33 variables
relevant to any decisions using radiotherapy in the treatment of
rectal cancer. Relevant demographic data was collected and pattern
of radiotherapy use was indicated.
Ethical approval was obtained from the Sydney SouthWest Area
Health Service Ethics Review Committee, Royal Prince Alfred Hos-
pital zone.
The survey was distributed to the surgeons of the Colorectal
Surgical Society of Australia and New Zealand (CSSANZ). The re-
sponses were statistically analysed using IBM SPSS Statistics
Version 19. The importance of the 33 variables was assessed using
medians and minimum and maximum scores. The variables were
also analysed in one of the following categories: tumour charac-
teristics, external inﬂuences, treatment outcomes, patient charac-
teristics, and side effects. The individual surgeon’s response to each
variable in these categories was used to calculate a mean category
score.
Wilcoxon Signed Rank test was used to assess for signiﬁcant
differences between the importances assigned to the variables. The
Friedman test was used for comparing differences between re-
sponses to 3 or more variables and post hoc analysis withWilcoxon
Signed Rank test if a P-value of less than 0.05 was calculated. A
Bonferroni adjustment was made to the level of signiﬁcance to
control for a Type 1 error.
The groups used for further univariate analysis were age (49 or
50 years of age), location of subspeciality training (Within or
outside Australia), main practise location (quaternary/tertiary
referral centre or peripheral/rural centres) and access to radio-
therapy (with or without radiotherapy service located in their main
hospital). Statistically signiﬁcant differences (P < 0.05) between
demographic groups were assessed using Mann Whitney U uni-
variate analysis.
Effect size statistic (r) was estimated by dividing the z value by
the square root of the total number of cases in the group. The Cohen
criteria were used for effect size: 0.1 ¼ small effect, 0.3 ¼ medium
effect and 0.5 ¼ large effect.
3. Results
152 surgeons were sent the questionnaire and 107 (70%)
responded, of which 105 were eligible.
3.1. Overall importance assigned to variables
The variables assigned greatest importance (Md ¼ 10) were
‘tumour stage’ and a ‘desire to reduce local recurrence’. The next most
important variables (Md ¼ 9) were ‘desire to downstage tumour to
maximise chance of resection with clear radial margins’, ‘staging with
MRI’, ‘tumour at lower third of rectum’ and ‘evidence supporting
radiotherapy’. The two variables allocated least importance, with a
median of 1, were ‘downstage tumour to allow transanal excision of
early cancer’ and ‘to permit a wait and see approach’ (Table 1).
Overall, the highest ranking variable with direct subjective pa-
tient impact was ‘desire to avoid functional bowel problems’ which
had a median importance of 7, but 12 other variables were assigned
greater median importance in the decision making on radiotherapy
in the treatment of rectal cancer (Table 1).3.2. Differences between categories
When the CSSANZ surgeons’ responses were considered in
categories (Table 2), it is interesting to note that the average
importance given to the “side effects” category is signiﬁcantly less
than the average for the “tumour characteristics” category (4.9 vs.
7.0, t(104) ¼ 11.19, P < 0.001 (two-tailed)). The “tumour charac-
teristics” category had the highest average importance, signiﬁ-
cantly higher than “external inﬂuences” (95% CI from 0.1 to 0.7,
t(104) ¼ 2.79, P ¼ 0.01).
3.3. Differences between demographic groups
103 surgeons completed the questions related to demographics
and radiotherapy practise. There were statistically signiﬁcant dif-
ferences between the median (Md) importance placed on variables
by different groups of surgeons.
Surgeons aged less than 50 years (n¼ 56) assigned a statistically
signiﬁcant higher median importance to tumour stage, than sur-
geons aged 50 or more (n ¼ 47) (10 vs. 9, P ¼ 0.04). However, the
effect size was small (r ¼ 0.2). Younger surgeons placed greater
importance on ‘desire to minimise sexual dysfunction’ compared to
older surgeons (5 vs. 4, P ¼ 0.03). Older surgeons placed slightly
more importance on ‘to permit a wait and see approach’ than
younger surgeons (1 vs. 0.5, P ¼ 0.03).
Surgeons whose colorectal surgery training occurred within
Australia (n ¼ 61) placed more importance on ‘patient gender’ than
those trained outside of Australia (n ¼ 42) (3 vs. 1, P ¼ 0.05).
Table 2
Mean importance score for variable categories. Calculated from ranking of impor-
tance by 105 CSSANZ surgeons (see below for variables within each category).
Category Mean importance score (Std dev)
Tumour characteristicsa 7.0 (1.1)
External inﬂuencesb 6.6 (1.4)
Treatment outcomesc 5.6 (1.4)
Patient characteristicsd 4.9 (2.0)
Side effectse 4.9 (2.1)
a Tumour characteristics: tumour stage, Staging with MRI, Tumour at lower third
of rectum, Nodal status, Distance from anal verge, Tumour at middle third of rectum,
Tumour position, Presence of resectable metastatic disease, Staging with transanal
ultrasound, Tumour at upper third of rectum.
b External Inﬂuences: Evidence supporting radiotherapy, Consensus of MDT, Your
personal experience or observations, Experience, observations and opinions of
colorectal surgical colleagues.
c Treatment Outcomes: Desire to reduce rate of local recurrence, Desire to
downstage tumour to maximise chance of resection with clear radial margins,
Downstage tumour to allow resection, Desire to maximise overall survival, Desire to
downstage tumour in order to preserve anal sphincter, Desire to avoid permanent
stoma, Downstage tumour to allow transanal excision of early cancer, To permit a
’wait and see’ approach.
d Patient Characteristics: Your patient’s ASA, Your patient’s age, Patient’s gender.
e Side Effects: Desire to avoid functional bowel problems, Desire to minimise
chance of long term pelvic pain, Desire to avoid urinary problems, Desire to mini-
mise chance of sexual dysfunction, Desire to minimise chance of pelvic sepsis, Desire
to minimise chance of wound infection.
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placed greater importance on ‘desire to avoid a permanent stoma’
than surgeons practising in a tertiary centre (n ¼ 79) (5.5 vs. 3,
P¼ 0.03). Interestingly, they also placed more importance on ‘desire
to downstage tumour in order to preserve anal sphincter’ than tertiary
based surgeons (7 vs. 4, P ¼ 0.03). Furthermore, these surgeons
placed more importance on the complications ‘desire to avoid uri-
nary incontinence’, ‘desire to minimise chance of post operative pelvic
sepsis’ and ‘desire to minimise chance of wound infection’ (Table 3).
The only variable that differed between surgeons with an on-
site radiotherapy service (n ¼ 80) and those with no radiotherapy
on-site (n ¼ 23) was ‘Downstage tumour to allow transanal excision
of early cancer’. (2 vs. 0, P ¼ 0.02).4. Discussion
This study provides a nascent insight into decisions when using
radiotherapy in the treatment of rectal cancer. Decisions that are
made in an uncertain, and time poor, environment are more likely
to be heuristic (System 1) and utilise a set of cues [11]. Experienced
decision makers, in suitable environments, can make accurate de-
cisions using System 1 [12]. The hierarchy of variables developed by
this study may reﬂect that tumour characteristics are likely to be
the key variables, or cues, used in decision making in this complex
ﬁeld (Tables 1 and 2).
Studies on decision making in uncertainty that show heuristic
decisions are vulnerable to bias. In this study there were small butTable 3
Comparison of median importance placed on side effects by 24 surgeons based in
rural and peripheral hospitals and 79 surgeons based in tertiary referral centres
(only statistically signiﬁcant variables shown).
Variable Peripheral/
rural hospital
Tertiary
hospital
P
value
Z
value
r
value
Desire to avoid urinary problems 6.0 4.0 0.05 1.95 0.2
Desire to minimise chance of post
operative pelvic sepsis
5.5 4.0 0.02 2.29 0.2
Desire to minimise chance of
wound infection
5.0 3.0 0.01 2.54 0.3statistically signiﬁcant differences in themedian importance placed
on different variables when surgeon demographic groups were
subjected to univariate analysis. This suggests that age, training,
site of practice, and the availability of radiotherapy are associated
with subtle differences in the importance assigned to multiple
variables, when deciding to use radiotherapy in the treatment of
rectal cancer. Such differences could indicate that decision making
in this context is open to the surgeon’s predisposition. It is not
surprising that CSSANZ surgeons exhibit innately human charac-
teristics by showing bias according to age, training, site of practise
and availability but this is the ﬁrst time it has been studied and
detected. These biases do not necessarily lead to poor decisions but
can impact on intuitive decision making [13]. Insight into useful
biases is important for assessing decision quality. It is also useful in
teaching decision making and minimizing errors [14].
Multidisciplinary team (MDT) meetings are the mainstay of
cancer treatment decisions in many countries. An understanding of
decision making by surgeons considering rectal cancer treatment
could be considered irrelevant as treatment decisions are made by
an MDT. Yet there is no universally accepted MDT model [15].
Furthermore, time pressures and a lack of standardization may
indicate that an understanding of the decision making process
would be useful to formulate a MDT template for the minimum
information to be presented at MDT meetings [16,17]. Such tem-
plates may address some of the concerns identiﬁed in the literature
and the variables identiﬁed in this study provide a starting point for
this.
Our study also identiﬁes that patient characteristics have a
lower overall importance rating by surgeons which is relevant to
other evidence which shows that patient choice is considered
infrequently in MDT and a lack of patient information is one of the
main reasons for not implementing MDT decisions [17,18]. If a
streamlined decision making MDT template is to be formulated
then decision making by all participants, most importantly the
patient, should be understood. Further investigation of decision
making by surgical, medical and radiation oncologists and patients
will be useful in improving MDT.
The differences associated with a surgeon’s location of practise
are interesting. The greater importance assigned to a desire to avoid
three of the potential side effects (Table 3) of radiotherapy may be
representative of a strategy by surgeons in peripheral or rural
hospitals to take on cases that are appropriate to the expertise of
their hospital. Smaller centres may not have the additional re-
sources to safely accept and treat highly complicated patients,
while tertiary referral centres are expected to treat such patients.
Surgeons in tertiary centres may have a higher rate of complica-
tions related to the resources required to treat high-risk patients
and, familiarity permits them to place less importance on these
variables when making difﬁcult treatment decisions.
There may be a similar process at play in the peripheral/rural
surgeon’s desire to avoid a permanent stoma or to preserve the anal
sphincter. Stoma therapists are less accessible in some peripheral/
rural centres, which conceivably introduce a bias toward avoiding
stomas.
It is also remarkable that even in the controversial environment
of radiotherapy use in rectal cancer treatment there are many
similarities in the importance grading by surgeons. This suggests
that CSSANZ surgeons use a similar subset of variables in the
numerous situations requiring decisions on radiotherapy in rectal
cancer treatment but at times they may place additional weight on
some variables that may be inﬂuenced by personal preferences due
to age, training, site of practice and availability of radiotherapy.
The authors hope to use these results to inﬂuence patient care
and optimize rectal cancer surgery by applying them to an analysis
of the individual and group MDT decision making in our hospital, a
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drawing attention to the cognitive and various input aspects of the
decisions that are being made, but it will subsequently feedback to
the same clinicians of the relevance, or not of the MDT process
when factored into their patient care.
The ability to draw far-reaching conclusions from this study is
limited by relatively conﬁned distribution of the questionnaire and
the reality that the process of decision making is much more
complex than applying different weighting to just 33 variables.
However, the high response rate does provide some insight into the
mindset of colorectal surgeons in Australia and New Zealand
involved in rectal cancer treatment. Understanding decision mak-
ing in these surgeons could have applications to training and MDT.
5. Conclusion
This study has shown some notable characteristics relating to
both the median importance placed on the presented variables and
to decision making by CSSANZ surgeons. It demonstrates that there
is a subset of variables that are the primary cues for decisions when
considering radiotherapy in the treatment of rectal and may be
useful in understanding how clinical decisions are made.
It has also demonstrated that there is enough diversity between
subsets of CSSANZ surgeons to suggest that decision making is
inﬂuenced by age, training, site of practise and access to radio-
therapy. This does not indicate that some decisions are necessarily
poor quality or incorrect but it could be argued that it is not rational
for such differences to exist and support a hypothesis that irrational
mechanisms for decision making exist.
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